St. Jude Medical Completes Acquisition of Thoratec
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St futures kick off September under pressure as yields, oil prices rise
- Oil up about 2% as renewed US-Iran strikes stoke supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
S&P Cuts St. Jude Medical (STJ) to 'A-' Following Closure of Thoratec Deal
October 8, 2015 5:08 PM EDTStandard & Poor's Ratings Services lowered its ratings on St. Jude Medical Inc. (NYSE: STJ), including the corporate credit rating and all issue-level ratings to 'A-' from 'A'. At the same time, we removed the ratings from CreditWatch, where we placed them with negative implications on July 22, 2015. The outlook is negative.
In conjunction with the... More
St. Jude Medical (STJ) Announces Completion of $3.3B Thoratec Acquisition
October 8, 2015 4:39 PM EDTSt. Jude Medical (NYSE: STJ) announced it has completed the previously announced acquisition of Thoratec Corporation, a worldwide leader in mechanical circulatory support (MCS) technology for the treatment of advanced heart failure (HF).
The acquisition will add the HeartMate II® VAD, the most widely used and extensively studied left ventricular assist device (VAD), as well as the next generation HeartMate 3, HeartMate PHP devices and other complementary products to St. Jude Medicals market-leading heart failure portfolio. With the addition of these product lines, St.... More
